| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.076 | 0.1 |